Genitourinary System for the Gynecologic Oncologist Webinar

The webinar titled Genitourinary System for the Gynecologic Oncologist was held live March 25th. The recording is now available. This free online webinar was made possible with support in part by Intuitive.

Evidence-Based Practice

Dear Colleagues and Friends of IGCS: Data from important studies assist physicians, patients, and government regulators to make informed decisions. In oncology, we have established clinical research as a routine part of our day to day patient care. Investigators in cancer clinical trials aim to provide results which educate both patients and clinicians, particularly utilizing randomized, usually blinded, clinical trial formats to compare different groups of otherwise-similar patients. Clinical advances in the area of therapeutics and gynecological malignancies recently published in The Lancet and Nature include the use of PARP INHIBITORS, both in BRCAgm and BRCAwt patients in the setting of recurrent ovarian cancer and, recently, in first line with the results of SOLO-1. Not since the introduction of cis-Platinum 30 years ago have we seen such exciting results in the management of women with ovarian malignancies. These trials have been well designed and conducted, have been published in highly regarded journals and need to be discussed when informing patients about their treatment options. Furthermore, they emphasize the importance of genetic testing in terms of prognosis and treatment options. Recently, two major surgical studies have been published in The New England Journal of Medicine. The first is a well thought out and rigorous surgical trial published at the end of October entitled “Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical

View Full Post